PAD - Prescribing Advisory Database
Surrey
Prescribing Advisory Database

Qvar Autohaler (beclometasone) breath activated MDI : Asthma

Detail

Condition :
Asthma
Keywords :
ICS, inhaled corticosteroids, respiratory, asthmatics
BNF Codes :
030200 - Corticosteroids (Respiratory)

Committee Recommendations

Date
Committee Name
Narrative
Traffic Light Status
04 November 2020
Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)

The Qvar Autohaler is not a locally preferred device and should not be initiated in new patients.
Consider Qvar Easi-Breathe in patients requiring a Qvar breath activated device.

Clenil Modulite® (beclometasone) MDI plus spacer (Volumatic, Able Spacer, Optichamber) or Qvar (beclometasone) MDI plus spacer (Aerochamber plus, Able Spacer, Optichamber) are the locally preferred ICS devices.

Other locally recommended devices are:
Easyhaler® Beclometasone (DPI) - not licensed in under 18 years
Easyhaler® Budesonide may be considered as an additional alternative in patients aged 12-17 if these other preferred, licensed devices are not suitable

Prescribe inhaler devices by BRAND

 
Do not initiate in new patients

Documents

Type
Document
Review Date
Guidelines (Local)
January 2024
Guidelines (Local)
November 2018
Guidelines (National)
Patient resource
Patient resource

Supplementary documents (CCG specific documents)

No records returned.

Drugs

Below are listed drugs that are used to treat Asthma.